Evidence map›Paper›PMID 33086524›Full record

ArticleInternational journal of environmental research and public health2020

Impact of Non-Tailored One-Way Automated Short Messaging Service (OASMS) on Glycemic Control in Type 2 Diabetes: A Retrospective Feasibility Study.

Ahmad Alamer, Charles Palm, Abdulaziz S Almulhim, Charisse Te, Merri L Pendergrass, Maryam T Fazel

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ahmad AlamerCenter for Health Outcomes and Pharmaco-Economic Research, University of Arizona College of Pharmacy, Tucson, AZ 85721, USA.
Charles PalmBanner-University Medicine Endocrinology and Diabetes Clinic, Tucson, AZ 85714, USA.
Abdulaziz S AlmulhimDepartment of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-3727-7543
Charisse TeBanner-University Medicine Endocrinology and Diabetes Clinic, Tucson, AZ 85714, USA.
Merri L PendergrassBanner-University Medicine Endocrinology and Diabetes Clinic, Tucson, AZ 85714, USA.
Maryam T FazelBanner-University Medicine Endocrinology and Diabetes Clinic, Tucson, AZ 85714, USA.
University of Arizona · USBanner - University Medical Center Tucson · USKing Faisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short message service (SMS) is easily accessible and potentially an ideal platform for delivering patient-targeted messages. However, an effective SMS dosing strategy is not well established. Our purpose was to evaluate the impact of diabetes self-care promoting messages via non-tailored one-way automated SMS (OASMS) on glycemic control in type 2 diabetes (T2DM). The change in hemoglobin A1c (HbA1c) was compared between patients who received the service and those who did not. This retrospective quasi-experimental pre-post feasibility study was conducted at an academic medical center endocrinology clinic. English-speaking adults (≥18 years) with uncontrolled T2DM (HbA1c ≥ 8%) were included. A total of 69 patients (intervention

Indexed as

Diabetes Mellitus, Type 2Glycemic ControlText MessagingAdultAgedFeasibility StudiesFemaleGlycated HemoglobinHumansMaleMedicareMiddle AgedRetrospective StudiesUnited StatesGlycated Hemoglobinhemoglobin A1c protein, humanautomatedglycemic controlnon-tailoredone-wayshort messagingSMStype 2 diabetesuncontrolled diabetes

Identifiers

PMID33086524
PMCPMC7593936
OpenAlexW3092984422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.